ZA958838B - The use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy - Google Patents

The use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy

Info

Publication number
ZA958838B
ZA958838B ZA958838A ZA958838A ZA958838B ZA 958838 B ZA958838 B ZA 958838B ZA 958838 A ZA958838 A ZA 958838A ZA 958838 A ZA958838 A ZA 958838A ZA 958838 B ZA958838 B ZA 958838B
Authority
ZA
South Africa
Prior art keywords
therapy
vwf
antithrombotic
employed
combination
Prior art date
Application number
ZA958838A
Other languages
English (en)
Inventor
Martin Reers
Gerhard Dickneite
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA958838B publication Critical patent/ZA958838B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA958838A 1994-10-20 1995-10-19 The use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy ZA958838B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437544A DE4437544A1 (de) 1994-10-20 1994-10-20 Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika

Publications (1)

Publication Number Publication Date
ZA958838B true ZA958838B (en) 1996-05-13

Family

ID=6531287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958838A ZA958838B (en) 1994-10-20 1995-10-19 The use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy

Country Status (20)

Country Link
US (1) US5571784A (xx)
EP (1) EP0713881A3 (xx)
JP (1) JPH08208504A (xx)
KR (1) KR960013383A (xx)
CN (1) CN1128168A (xx)
AU (1) AU708670B2 (xx)
CA (1) CA2160975A1 (xx)
CZ (1) CZ287878B6 (xx)
DE (1) DE4437544A1 (xx)
FI (1) FI954964A (xx)
HR (1) HRP950525A2 (xx)
HU (1) HU219595B (xx)
IL (1) IL115652A (xx)
NO (1) NO954175L (xx)
NZ (1) NZ280274A (xx)
PL (1) PL183182B1 (xx)
SK (1) SK129695A3 (xx)
TW (1) TW398977B (xx)
UY (1) UY24063A1 (xx)
ZA (1) ZA958838B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
JP2003284570A (ja) 2001-04-25 2003-10-07 Chemo Sero Therapeut Res Inst フォンビルブラント因子（ｖＷＦ）切断酵素
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
CN102770449B (zh) * 2010-02-16 2016-02-24 诺沃—诺迪斯克有限公司 具有降低的vwf结合的因子viii分子
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
TWI580423B (zh) * 2013-12-24 2017-05-01 財團法人工業技術研究院 緩解或治療痛風之醫藥組合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2619314B1 (fr) * 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
GB8823480D0 (en) 1988-10-06 1988-11-16 Ciba Geigy Ag Antidote
US5204323B1 (en) 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
DE4115453A1 (de) 1991-05-11 1992-11-12 Knoll Ag Neue wirkstoffkombination
US5366869A (en) * 1991-11-08 1994-11-22 Sheldon Goldstein Multiple coagulation test device and method
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
ZA942818B (en) * 1993-04-23 1995-01-30 Bio Technology General Corp Method of enhancing thrombolysis.
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung

Also Published As

Publication number Publication date
PL311031A1 (en) 1996-04-29
TW398977B (en) 2000-07-21
DE4437544A1 (de) 1996-04-25
IL115652A (en) 2000-08-31
JPH08208504A (ja) 1996-08-13
HU9503031D0 (en) 1995-12-28
CA2160975A1 (en) 1996-04-21
SK129695A3 (en) 1996-10-02
UY24063A1 (es) 1995-10-24
HUT73762A (en) 1996-09-30
CZ287878B6 (cs) 2001-03-14
FI954964A0 (fi) 1995-10-18
AU708670B2 (en) 1999-08-12
NO954175D0 (no) 1995-10-19
KR960013383A (ko) 1996-05-22
IL115652A0 (en) 1996-01-19
EP0713881A2 (de) 1996-05-29
US5571784A (en) 1996-11-05
CN1128168A (zh) 1996-08-07
CZ271995A3 (en) 1996-05-15
NZ280274A (en) 1997-01-29
PL183182B1 (pl) 2002-06-28
NO954175L (no) 1996-04-22
HU219595B (hu) 2001-05-28
AU3430495A (en) 1996-05-02
FI954964A (fi) 1996-04-21
HRP950525A2 (en) 1997-04-30
EP0713881A3 (de) 1996-08-21

Similar Documents

Publication Publication Date Title
GB2274901B (en) Suction catheter assemblies and valves
ZA932434B (en) Evaluation and treatment of patients with progressive immunosuppression
KR100321237B1 (ko) 적층구조물
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
GB9323044D0 (en) In or relating to the treatment of effluents
EP0584340A4 (en) Diagnosis and treatment of various neuralgias
ZA958838B (en) The use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
GB2275029B (en) Improvements in and relating to wheelchairs
SG47611A1 (en) Improvements in or relating to clamps and the use thereof
HU9500841D0 (en) Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity
GB2224969B (en) Improvements in and relating to the manufacture of laminates
GB9319499D0 (en) Improvements in and relating to the shaping of articles
AU3114295A (en) Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
EP0575826A3 (en) Reactive polyurethanes and their use
ZA945555B (en) Benzoxazinones and benzothiazinones with therapeutic activity
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
GB9401468D0 (en) Improvements in and relating to the arrangement of loads
IL94396A0 (en) Methods and mechanisms of connection between tissues in the human body
GB8901034D0 (en) Improvements in and relating to suction treatment of the body
GB9410958D0 (en) Ankle and lower body exerciser
AU123432S (en) A section
GB9304611D0 (en) Improvements in or relating to occasional tables and the like
GB9421772D0 (en) Improvements in and relating to the manufacture of a formed metal part
GB9301011D0 (en) Improvements in and relating to inhaling devices